STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

SAB Biotherapeutics, Inc.

Filed

October 1, 2025

Period of Report

September 29, 2025

Accession Number

0001012975-25-000592